TRV GP III, LLC - Q1 2022 holdings

$369 Million is the total value of TRV GP III, LLC's 7 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
RVMD  REVOLUTION MEDICINES, INC.$140,918,000
+1.4%
5,524,0310.0%38.24%
+9.9%
FULC  FULCRUM THERAPEUTICS, INC.$93,706,000
+33.7%
3,962,2020.0%25.43%
+45.0%
VYGR  VOYAGER THERAPEUTICS, INC.$48,701,000
+181.2%
6,391,1760.0%13.22%
+204.9%
PLRX  PLIANT THERAPEUTICS, INC.$40,933,000
-48.1%
5,839,1600.0%11.11%
-43.7%
NRIX SellNURIX THERAPEUTICS, INC.$26,935,000
-61.6%
1,922,549
-20.6%
7.31%
-58.4%
DBTX  DECIBEL THERAPEUTICS, INC.$9,545,000
-34.6%
3,139,6850.0%2.59%
-29.1%
JNCE  JOUNCE THERAPEUTICS, INC.$7,800,000
-18.7%
1,148,7800.0%2.12%
-11.8%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Mark Levin #1
  • Kevin P. Starr #2
  • Robert I. Tepper #3
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VOYAGER THERAPEUTICS, INC.22Q1 202374.0%
JOUNCE THERAPEUTICS, INC.20Q3 202224.5%
PLIANT THERAPEUTICS, INC.14Q3 2023100.0%
FULCRUM THERAPEUTICS, INC.14Q4 202243.8%
REVOLUTION MEDICINES, INC.12Q4 202253.8%
DECIBEL THERAPEUTICS, INC.10Q2 202366.3%
NEON THERAPEUTICS, INC.8Q1 202041.1%
NURIX THERAPEUTICS, INC.8Q2 202217.7%
RELAY THERAPEUTICS, INC.2Q4 202037.7%
MYOKARDIA, INC.2Q1 201822.1%

View TRV GP III, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR2023-05-12
13F-HR2023-02-14
42023-02-06
42023-02-01
42023-01-31
42023-01-26
42023-01-24

View TRV GP III, LLC's complete filings history.

Compare quarters

Export TRV GP III, LLC's holdings